What is CROMSOURCE?
Founded in 1994 and headquartered in Waltham, Massachusetts, CROMSOURCE operates as an ISO-certified contract research organization (CRO). The company provides a comprehensive portfolio of clinical trial services, catering specifically to the complex needs of the pharmaceutical, biotechnology, and medical device sectors. Through its rigorous adherence to quality standards and its expansive operational reach, CROMSOURCE has established itself as a critical partner for life sciences companies navigating the intricacies of global regulatory environments. The firm's expertise spans the entire clinical development lifecycle, ensuring that clients can effectively manage trial design, data management, and regulatory submissions with precision and efficiency.
How much funding has CROMSOURCE raised?
CROMSOURCE has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in CROMSOURCE
PPP
Public-Private Partnership
What's next for CROMSOURCE?
With the successful acquisition of this major strategic investment, CROMSOURCE is poised to scale its operational infrastructure and deepen its technological integration within clinical trial management. The company is expected to prioritize the expansion of its digital health initiatives and the optimization of its decentralized trial frameworks, which have become increasingly vital in the post-pandemic research landscape. By focusing on high-growth therapeutic areas and enhancing its global site network, CROMSOURCE aims to solidify its competitive advantage. This capital injection serves as a catalyst for long-term growth, enabling the firm to pursue strategic partnerships and potential service line diversification that will further cement its status as a leader in the contract research industry.
See full CROMSOURCE company page
